EU Business News: BioGaia Acquires US Distributor, Spain's Rubió Enters VMS Market, Sidefarma Gets PE Backing
Executive Summary
Round-up of European consumer health news: Probiotics specialist BioGaia plots US expansion with acquisition of distribution partner; Spain's Rubió enters the dietary supplements space with Fisiopharma; and Portugal's Sidefarma receives investment from private-equity firm Atena.
You may also be interested in...
With Investor Support Thin On The Ground, Unilever Won't Up Bid For GSK Consumer Healthcare
Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.
Alliance Pharma Eyes OTC Acquisitions Following Strong 2021
UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.
France Adds 12 OTCs To Free Access List
France's medicines regulator ANSM has added 12 OTCs to its "free access" list of products available for self-selection by consumers in pharmacies.